Q1 2020 Aurobindo Pharma Ltd Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q1 FY '19-'20 Earnings Call of Aurobindo Pharma Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Krishna Kiran, Investor Relations. Thank you, and over to you, sir.
Thank you, Margaret. Good morning, and a warm welcome to our first quarter FY '20 earnings call. I am Krishna Kiran from the Aurobindo Pharma Investor Relations. We hope you have received the Q1 FY '20 financials and the press release that we've sent out yesterday. These are also available on our website.
With me, we have our senior management team represented by Mr. N. Govindarajan, Managing Director; Mr. Sanjeev Dani, COO, Head Formulations; Mr. Santhanam Subramanian, CFO; Mr. Swami Iyer, CFO, Aurobindo Pharma USA. We will begin the call with summary highlights from the management followed by an interactive Q&A session.
Please note that some of the matters we will discuss today are forward looking,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
